Haemonetics (HAE) Gross Profit Margin starting from the first quarter 2026 to first quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Haemonetics Corporation  (NYSE: HAE)


Haemonetics's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HAE Gross Profit Margin (Jun 27 2026)
Q1 		(Mar 28 2026)
Q4 		(Dec 27 2025)
Q3 		(Sep 27 2025)
Q2 		(Jun 28 2025)
Q1
Y / Y Revenue Change 5.65 %
Seq. Revenue Change -2.26 %
Revenue In Millions $339.38
Gross Profit Margin 59.76 %
Gross Profit Margin Total Ranking # 1463
Gross Profit In Millions $202.80
Y / Y Gross Profit Change 5.49 %
Seq. Gross Profit Change 2.32 %


Commenting First Quarter 2026 Gross Profit Margin
Haemonetics Corporation achieved Gross Profit of $203 millions compare to Gross Loss of $198.21 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q1 of -2.26 % Haemonetics Corporation managed to reduce Cost of Sales and increase Gross Profit by 2.32 % to $203 millions. Gross Profit Margin grew to 59.76 %, above company average Gross Profit Margin.


Observing first quarter 2026 results within Medical Equipment & Supplies industry 103 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1463, from total ranking in the previous quarter at 1474.
Learn about Gross Margin
HAE's Gross Profit Margin first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 104
Healthcare Sector # 269
Overall # 1452

Gross Profit Margin Statistics
High Average Low
59.84 % 49.32 % 36 %
(Jun 28 2025)   (Apr 01 2017)


HAE Gross Income Trends • More of HAE's Profitabilty Ratios • HAE Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
HAE's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
HAE's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for HAE's Competitors
Gross Profit Margin Profit Margin for Haemonetics's Suppliers
Gross Profit Margin Profit Margin for HAE's Customers

You may also want to know
HAE's Annual Growth Rates HAE's Profitability Ratios HAE's Asset Turnover Ratio HAE's Dividend Growth
HAE's Roe HAE's Valuation Ratios HAE's Financial Strength Ratios HAE's Gross Profit Growth
HAE's Roa HAE's Inventory Turnover Ratio HAE's Growth Rates HAE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 27 2026, within Medical Equipment & Supplies Industry Gross Profit MarginJun 27 2026 MRQ Gross ProfitJun 27 2026 MRQ Revenue
Agape Atp Corporation  98.24 %$ 0.107  Millions$ 0.109  Millions
Invo Fertility Inc   97.24 %$ 2.115  Millions$ 2.175  Millions
Sanara Medtech Inc   92.96 %$ 26.155  Millions$ 28.137  Millions
Ceribell Inc   92.32 %$ 25.938  Millions$ 28.097  Millions
Sight Sciences Inc   91.39 %$ 21.374  Millions$ 23.388  Millions
Seastar Medical Holding Corp  91.22 %$ 0.561  Millions$ 0.615  Millions
Delcath Systems Inc   89.75 %$ 26.148  Millions$ 29.133  Millions
Cvrx inc   87.39 %$ 13.724  Millions$ 15.705  Millions
Trisalus Life Sciences Inc   86.78 %$ 9.899  Millions$ 11.407  Millions
Electrocore Inc   86.53 %$ 8.177  Millions$ 9.450  Millions
Sharps Technology Inc   86.06 %$ 1.755  Millions$ 2.039  Millions
Neuraxis Inc   85.87 %$ 1.656  Millions$ 1.929  Millions
Inspire Medical Systems inc   85.48 %$ 171.459  Millions$ 200.581  Millions
Mobia Medical Inc   83.21 %$ 11.238  Millions$ 13.505  Millions
Heartflow Inc   83.00 %$ 53.190  Millions$ 64.082  Millions
Neuropace Inc   82.83 %$ 18.906  Millions$ 22.826  Millions
Vycor Medical Inc   82.35 %$ 0.344  Millions$ 0.418  Millions
Avita Medical Inc   81.87 %$ 17.767  Millions$ 21.702  Millions
Glaukos Corp  81.67 %$ 151.594  Millions$ 185.610  Millions
Si bone inc   79.54 %$ 44.548  Millions$ 56.010  Millions
Vaso Corporation  79.46 %$ 8.889  Millions$ 11.187  Millions
Electromed Inc   78.71 %$ 15.284  Millions$ 19.417  Millions
Treace Medical Concepts Inc   78.47 %$ 35.607  Millions$ 45.376  Millions
Profound Medical Corp   78.41 %$ 1.947  Millions$ 2.483  Millions
Pulmonx Corporation  77.97 %$ 17.742  Millions$ 22.756  Millions
Novocure Limited  77.61 %$ 142.478  Millions$ 183.584  Millions
Edwards Lifesciences Corporation  77.46 %$ 1,348.600  Millions$ 1,741.000  Millions
Atricure Inc   77.23 %$ 118.629  Millions$ 153.604  Millions
Anteris Technologies Global Corp   76.91 %$ 0.776  Millions$ 1.009  Millions
Carlsmed Inc   76.78 %$ 14.542  Millions$ 18.940  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.